Duchenne Muscular Dystrophy Dmd clinical trials

Explore recruiting duchenne muscular dystrophy dmd clinical trials.

Recruiting duchenne muscular dystrophy dmd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Duchenne Muscular Dystrophy Dmd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Open-Label Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)

Belgium, Italy, Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping with an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-44, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-44 (ELEVATE-44)

Spain, Belgium, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping with an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-45, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-45 (ELEVATE-45)

Netherlands, Italy, Spain, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 3, Multi-Center, Open Label Extension Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys with Duchenne Muscular Dystrophy (DMD)

Spain, Italy, Greece, Norway, Czechia, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label, Systemic Gene Delivery Study to Evaluate the Safety, Tolerability and Expression of SRP-9001 in Association with Imlifidase in Subjects with Duchenne Muscular Dystrophy with Pre-existing Antibodies to rAAVrh74

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase II Multicenter, Open-Label Study to evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Pediatric Patients with Duchenne Muscular Dystrophy (SHIELD DMD)

Poland, Spain, Italy, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Duchenne Muscular Dystrophy Dmd trials by city

Duchenne Muscular Dystrophy Dmd in Toronto Duchenne Muscular Dystrophy Dmd in Vancouver Duchenne Muscular Dystrophy Dmd in Montreal Duchenne Muscular Dystrophy Dmd in Calgary Duchenne Muscular Dystrophy Dmd in Edmonton Duchenne Muscular Dystrophy Dmd in Ottawa Duchenne Muscular Dystrophy Dmd in Winnipeg Duchenne Muscular Dystrophy Dmd in Quebec City Duchenne Muscular Dystrophy Dmd in Hamilton Duchenne Muscular Dystrophy Dmd in Kitchener Duchenne Muscular Dystrophy Dmd in London Duchenne Muscular Dystrophy Dmd in Halifax Duchenne Muscular Dystrophy Dmd in New York Duchenne Muscular Dystrophy Dmd in Los Angeles Duchenne Muscular Dystrophy Dmd in Chicago Duchenne Muscular Dystrophy Dmd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease